Significance
Staphylococcus aureus
is an opportunistic pathogen of the normal human flora. It is among the most frequent causes of cutaneous abscesses, leading to life-threatening invasive infection. Incomplete understanding of host defenses against
S. aureus
skin or invasive infection has hindered development of effective vaccines to address these issues. NDV-3 is a unique cross-kingdom vaccine targeting
S. aureus
and
Candida albicans
. The present studies offer important new evidence: (
i
) NDV-3 protects against methicillin-resistant
S. aureus
skin and skin structure infection largely through IL-22– and IL-17A–mediated host defense peptide and neutrophil induction, (
ii
) vaccine-mediated IL-22 and IL-17A play distinct roles in protection against cutaneous versus invasive infection, and (
iii
) NDV-3 vaccine efficacy in this model involves a coordinated induction of innate and adaptive immunity.